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Hepatitis B virus (HBV) replicates its DNA genome via reverse transcription. Precise roles of the ter-
minal protein domain of HBV polymerase remain unknown. To gain insight, we created alanine sub-
stitution mutations at hydrophobic residues (i.e., tyrosine, tryptophan, and isoleucine), and then
examined the extent by which these mutants carry out viral genome replication. Evidence indicated
that three hydrophobic residues of the terminal protein domain (i.e., W74, Y147, and Y173) contrib-
ute to distinct steps of viral genome replication: the former two residues are important for viral DNA
synthesis, while the latter is important for viral RNA encapsidation.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Hepatitis B virus (HBV) is the prototypic member of the hepa-
dnavirus family, which includes the duck hepatitis B virus (DHBV)
and the woodchuck hepatitis virus (WHV) [1]. HBV has a small
(approximately 3.2 kb) circular DNA genome that encodes the
nucleocapsid (core), polymerase (Pol), and envelope (surface anti-
gen) proteins and the X protein in a very compact, overlapping
arrangement. In addition to the RT and RNase H domains, which
are commonly encoded within retroviral RTs, HBV Pol gene en-
codes two additional domains at the N-terminus: (i) the terminal
protein (TP), and (ii) spacer domains [2] (Fig. 1). Little is known
about the contribution of the TP domain to viral genome replica-
tion. First, the TP domain serves as a protein primer for DNA syn-
thesis [1]. In particular, the tyrosine residue (i.e., Y63 in HBV) of
the TP domain primes viral DNA synthesis and covalently links
the HBV Pol to viral DNA, via a reaction called protein priming
[1]. Second, the TP domain is indispensable for RNA binding.
Speciﬁcally, in the case of DHBV Pol, the arginine residue critical
for RNA binding has been identiﬁed in the C-terminal conserved
region of TP domain, often referred to as the T3 motif [3,4]. Over-
all, the TP domain has been shown to contribute to distinct stepschemical Societies. Published by E
rase; TP, terminal protein
odaemun-gu, Seoul 120-749,of viral genome replication, such as RNA binding, capsid assembly,
and protein priming.
To gain further insight into the contribution of the TP domain,
we created mutations in several of the conserved hydrophobic res-
idues encoded by that region and examined the extent to which
each residue contributes to viral genome replication. The results
reveal that three out of the nine mutants have a defect in viral gen-
ome replication, and the defects lie at two distinct steps of viral
DNA synthesis: RNA encapsidation and an early step of minus-
strand DNA synthesis.
2. Materials and methods
2.1. Cell culture, transfection
HepG2 cells were grown in Dulbecco’s Modiﬁed Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (Gibco-BRL)
and 10 lg of gentamycin per ml at 37 C in 5% CO2 and were pas-
saged every third day. Cells were transfected using polyethyleni-
mine (PEI) (25 kDa, Sigma–Aldrich) as described [5].
2.2. Plasmid construction
The HBV P-null replicon construct was described previously [5].
pCMV-Pol, a HBV polymerase expression construct, was described
previously [5], from which HBV Pol with three copies of the Flag
epitope at N-terminus is expressed. All substitution and deletion
mutants were generated by overlap extension PCR protocols as pre-
viously described [6].lsevier B.V. All rights reserved.
Fig. 1. A diagram showing the positions of YWI residues of the TP domain of HBV Pol used in this study. The HBV Pol (P) can be divided into four subdomains: terminal
protein (TP), spacer domain, reverse transcriptase (RT), and RNase H domain (RH). The position of each altered amino acid is indicated below with the names of each mutant.
Two hydrophobic residues that reside within the T3 motif are denoted by a bracket. The invariant tyrosine residue (Y63) of the TP domain is denoted as well. N-terminal 3
Flag tag is denoted by a grey box.
Fig. 2. Analysis of the YWI mutants for their ability to support viral genome replication. (A) Southern blot analysis. HepG2 cells were cotransfected with the HBV P-null
construct (9 lg) along with WT or mutant Pol expression construct (1 lg per 60-mm plate), as indicated above each lane. Southern blot analysis was performed to detect the
HBV replication intermediates. Three replication DNA intermediates are indicated: RC, relaxed-circular DNA; DL, duplex-linear DNA; and SS, single-strand DNA (black
arrowheads). A restriction fragment representing one HBV genomic unit, 3.2 kb in size, serves as a size marker (SM; open arrowhead). The value for the WT was set to 100%.
Data presented are the means ± standard deviations from triplicate determinations. (B) RNase protection analysis (RPA) to measure the RNA encapsidation. Cells were
transfected by each Pol mutant plasmid along with HBV P-null replicon construct. Three days after transfection, cytoplasmic total RNAs (T) and core-associated RNA (C) were
extracted and subjected to RPA. Riboprobe and the protected pregenomic RNA are denoted by the open and closed arrowheads, respectively. Yeast RNA was used as a negative
control. The value for the WT was set to 100%. Error bars represent the standard deviation from three independent experiments. (C) Western blot analysis. Western blot
analysis of the HBV Pol was performed using an anti-Flag antibody. Actin served as a loading control.
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3.1. Mutation of the TP hydrophobic residues results in defects in viral
genome replication and RNA encapsidation
To gain insight into the TP domain, we sought to identify spe-
ciﬁc hydrophobic residues that might contribute to viral genome
replication. In particular, we focused on three kinds of hydrophobic
residues that are more likely to be involved in molecular interac-
tions: tyrosine (Y), tryptophan (W), and isoleucine (I) [7]. Align-
ment of the TP subdomain has revealed that nine hydrophobic
residues are conserved among hepadnaviruses (data not shown),
and the position of these residues is shown in Fig. 1. In particular,
two residues are encoded by a highly conserved segment at the
C-terminus of the TP domain, often referred to as the T3 motif
[3], while the rest of the residues are scattered in the C-terminal
two-third of the TP domain. Thus, we divided these hydrophobic
residues into two groups for further analysis: (i) seven individual
residues (Figs. 2–4), and (ii) residues in the T3 motif (Fig. 5).
To assess the contribution of these hydrophobic residues to viral
genome replication, we substituted each hydrophobic residue with
alanine (Fig. 1). Then, we examined the ability of each TP domain
mutant in supporting viral genome replication and pgRNA encapsi-
dation (Fig. 2). We employed a complementation strategy to exam-
ine theability of theHBVPolmutants to support viralDNAsynthesis,
as previously described [8]. Cells were transfected by an individual
Pol mutant along with a HBV 1.3mer replicon construct that ex-
presses pgRNA but harbors a frame-shift mutation in the P-ORF
(i.e., HBV 1.3mer P-null) [9]. At 4 d following transfection, the viral
DNA replication intermediates extracted from the isolated capsidsFig. 3. Analysis of phosphomimetic substitution mutants of two tyrosine residues of the
protection analysis (RPA). Symbols are the same as in Fig. 2B. (C) Western blot analysiswere analyzed by Southern blot analysis, which conﬁrmed that the
WT HBV Pol supports the synthesis of three species of HBV replica-
tion intermediates, as anticipated (Fig. 2A, lane 1). It was found that
three mutants (W74A, Y147A, and Y173A) failed to support viral
genome replication (Fig. 2A, lanes 2, and 6–7), while the other four
mutants supported viral genome replication comparable to wild
type (WT) (Fig. 2A, lanes 3–5 and 8).
To narrow down the speciﬁc step of viral genome replication in
which the aforementioned mutants were defective, we measured
encapsidation of the pgRNA, a step prior to viral genome replica-
tion. Cells were transfected, and 3 d following transfection cyto-
plasmic total RNA (T) as well as capsid-associated RNA (C) was
extracted and analyzed by RNase protection analysis (RPA)
(Fig. 2B). RNase protection assay revealed that all of the mutants,
with the exception of Y173A, supported pgRNA encapsidation
(Fig. 2B, lane 13); protein expression of all the mutant proteins
was conﬁrmed (Fig. 2C). Thus, we concluded that Y173A mutation
caused a defect in viral RNA encapsidation, whereas the W74A and
Y147A mutation caused a defect in viral DNA synthesis. The obser-
vation that no viral DNA replication intermediates were detectable
(Fig. 2A, lanes 2 and 6) suggested that HBV Pol derived from the
latter are defective in an early step of the minus-strand DNA
synthesis.
3.2. The hydroxyl group of Y147 residue is critical for viral reverse
transcription
Our data presented above indicated that Y147 residue is critical
for viral DNA synthesis (Fig. 2). As stated above, a tyrosine residue
frequently occupies the interfaces of protein–protein interactionTP domain. (A) Southern blot analysis. Symbols are the same as in Fig. 2A. (B) RNase
. Symbols are the same as in Fig. 2C.
Fig. 4. Evidence that Y173 residue is important for RNA binding. (A) Surrogate RNA
binding assay. Cells were cotransfected with a 1:3 ratio of WT (1 lg) and the
mutant Pol expression plasmids (3 lg), along with HBV P-null construct (9 lg) per
60-mm plate. Southern blot analysis was performed as shown in Fig. 2A. Symbols
are the same as in Fig. 2. Statistical analysis revealed that viral DNA level in lane 3
(Y63F/Y173A) is not different from that of lane 1 (WT; P > 0.05) as denoted by a
double asterisk, while viral DNA level in lane 3 (Y63F/Y173A) is different from that
of lane 2 (Y63F; P < 0.05) as denoted by a single asterisk. (B) Western blot analysis.
Fig. 5. Evidence that the hydrophobic residues of the T3 motif in HBV Pol are not
important for the viral DNA synthesis. (A) A diagram showing the T3 motif of avian
and mammalian hepadnavirus Pols. R183 residue of DHBV Pol, which was shown to
be essential for the RNA binding [3], is denoted by an asterisk. (B) Southern blot
analysis. (C) RPA to measure the RNA encapsidation. (D) Western blot analysis.
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residue is more relevant for its role in viral DNA synthesis. To as-
sess this possibility, we made three substitutions: (i) Y147F, in
which Y147 was substituted with phenylalanine, (ii) Y147D, an
aspartic acid substitution, and (iii) Y147E, a glutamic acid substitu-
tion. Y147F substitution should mimic unphosphorylated Y147, as
the phenylalanine substitution would prevent phosphorylation,
whereas Y147D and Y147E substitutions would mimic phosphory-
lated Y147, as aspartic acid or glutamic acid substitution contrib-
utes a negative charge that mimics phosphorylation. Southern
blot analysis showed that both two phosphomimetic substitution
mutants yielded no detectable viral DNA (Fig. 3A, lanes 3 and 4),
suggesting that the tyrosine phosphorylation is unimportant for
the viral DNA synthesis. In contrast, the Y147F mutant yielded a
modest level of viral DNA reproducibly; nonetheless, its level is
far less than that of theWT (Fig. 3A, lane 1 vs. 2). Our interpretation
is that the phenolic hydroxyl group of Y147 residue is far more
important for viral DNA synthesis than the phenol ring itself. The
RPA and Western blot performed in parallel conﬁrmed that the
three substitution mutants were not defective in RNA encapsida-
tion (Fig. 3B) and HBV Pol levels from three mutants were compa-
rable (Fig. 3C).
3.3. Phosphorylation of the Y173 residue is not essential for RNA
encapsidation
Our data presented above showed that HBV Pol derived from
Y173A is defective in viral RNA encapsidation (Fig. 2). As above,
we asked whether the phosphorylation of Y173 is essential forRNA encapsidation. Likewise, three substitution mutants were
made: Y173F, Y173D, and Y173E (Fig. 3A). Southern blot analysis
showed that all three mutants failed to support the viral DNA syn-
thesis to the WT level, although the Y173F mutant only modestly
supported viral DNA synthesis (Fig. 3A, lanes 5–7). This result was
not unexpected, since Y173A failed to support viral DNA synthesis
at all (Fig. 2A, lane 7). On the other hand, RPA showed that Y173E
supported the RNA encapsidation, whereas Y173D failed to do so
(Fig. 3B, lanes 11 and 13). Importantly, the observation that
Y173F (which cannot be phosphorylated) supports RNA encapsida-
tion led us to conclude that phosphorylation of the Y173 residue is
not essential for RNA encapsidation (Fig. 3B, lane 9).
3.4. Evidence that the Y173 residue is critical for RNA binding
In principle, it is possible that the Y173Amutant could be defec-
tive in either RNA binding or capsid assembly. To assess the former
possibility, we explored a surrogate RNA binding assay that we
established previously [8]. Brieﬂy, the RNA binding ability of the
3968 Y.-C. Shin et al. / FEBS Letters 585 (2011) 3964–3968mutant Pol was examined by its ability to inhibit the WT Pol in
supporting viral DNA synthesis. A mutant of interest was made
in the context of the Y63F mutation that abrogates the viral DNA
synthesis [10,11]. The results showed that the Y63F/Y173A double
mutant failed to inhibit the ability of WT Pol in supporting viral
DNA synthesis, suggesting that the Y63F/Y173A mutant lacks
RNA-binding ability (Fig. 4A, lane 3). Our interpretation is that
the Y173 residue is critical for RNA binding. Western blot analysis
conﬁrmed that the mutant proteins were comparably expressed
(Fig. 4B).
3.5. Hydrophobic residues encoded by the T3 motif residues are not
important for viral DNA synthesis
Lastly, we sought to examine two hydrophobic residues (i.e.,
I156 and Y158) encoded by the T3 motif (Fig. 1). Our reported anal-
ysis clearly showed that K159 and R160 residues of the T3 motif of
HBV Pol are tolerable to alanine substitution [12] (Fig. 5); nonethe-
less, it remained open whether the remaining ﬁve residues in the
T3 motif, if any, are important for viral genome replication. To re-
solve the issue, we included two additional T3 residues (i.e., G155
and L157) for the analysis. Thus, the four alanine substitutions (i.e.,
G155A, I156A, L157A, and Y158A) were examined individually for
effects on viral genome replication. As shown in Fig. 5B, Southern
blot analysis revealed that all four mutants supported viral genome
replication comparable to WT. Western blot analysis and RPA, per-
formed in parallel, indicates no effects of these mutations on RNA
encapsidation (Fig. 5C and D). The results indicate that all four res-
idues encoded by the T3 motif tolerate substitution. Thus, we con-
cluded that the T3 motif is dispensable for HBV Pol.
To attain insight into the roles of the TP domain of HBV Pol dur-
ing viral genome replication, we made a set of alanine substitution
mutations of nine conserved hydrophobic residues. We found that
a tyrosine residue (Y173) is essential for RNA encapsidation, while
a tryptophan (W74) and tyrosine (Y147) residue are important for
viral reverse transcription. Overall, the genetic analysis presented
here provides biochemical insight into the roles of the conserved
hydrophobic residues of the TP domain of HBV Pol.
One (W74) out of two tryptophan residues were found to be
important for viral genome replication, consistent with the notion
that tryptophan is most frequently found in protein–protein inter-
action interfaces [7]. In addition, two (Y147 and Y173) out of ﬁve
tyrosine residues were found to be important for viral genome
replication. Speciﬁcally, our YWI substitution mutants could be
divided into two groups, according to the step at which each muta-
tion exerted its effect: (i) Y173A, which is defective in RNA encaps-
idation, and (ii) W74A and Y147A, which are defective in viral
reverse transcription. Intriguingly, the phenotypes manifested by
substitution mutation at these residues could be largely attributed
to the aromatic rings and, to a lesser extent, to the hydroxyl group,
of the hydrophobic amino acids. It is likely that the aromatic rings
(or the hydroxyl group) are present in an inter- or intra-molecular
interaction interface necessary for viral genome replication. It
would be of great interest to identify binding partners, whether vir-
al and host factors, of the TP domain inﬂuenced by these aromatic
groups.
Discrepancies exist in the analysis of T3 motif between avian
and mammalian hepadnaviral Pols. In particular, it was shown thata double substitution of two hydrophobic residues of T3 motif (i.e.,
I179/L180) in DHBV, which correspond to I156/L157 of HBVayw
subtype, causes a defect in RNA binding [4]. One explanation for
the discrepancy is that these hydrophobic residues (I179/L180 in
DHBV) are, indeed, indispensable for the RNA binding in DHBV
Pol, but not in HBV Pol, reﬂecting the divergence between avian
and mammalian hepadnaviral Pols. Alternatively, it is also possible
that the indispensability found in DHBV is a consequence of non-
conservative substitution (i.e., I179D/I180D).
Our analysis reveals that the hydrophobic contact point of the
TP domain is critical for distinct steps in viral genome replication,
including RNA encapsidation and viral reverse transcription. It is
hoped that further elucidation of the molecular interactions uncov-
ered here could lead to novel strategies for future therapeutic
intervention.
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